BIOMAT Database Logo BIOMAT Database Logo

Cyclic AMP metabolism in fragile X syndrome. 1992

E Berry-Kravis, and P R Huttenlocher
Department of Pediatrics, University of Chicago, IL.

Cyclic AMP (cAMP) metabolism was studied in platelets from a series of 14 patients with fragile X syndrome (fra X) and 21 control individuals. 1-Isobutyl-3-methylxanthine was used to inhibit phosphodiesterase and thus measure cAMP production, prostaglandin E1 was used to assess receptor-mediated cAMP accumulation, and forskolin was used to directly stimulate the catalytic subunit. In patients with fra X, basal production was 63% of that of control subjects (p = 0.019). Prostaglandin E1- and forskolin-stimulated production were 61% (p = 0.039) and 56% (p = 0.012) of that of control subjects, respectively. cAMP production in 8 patients with fra X overlapped the control range, whereas measures of production in 6 patients formed a cluster with values lower than any of the 21 control subjects assayed, suggesting possible biochemical heterogeneity within patients with fra X. Results obtained from the group of patients with fra X suggest possible abnormal function or regulation of the catalytic subunit of adenylate cyclase in at least a subgroup of patients with fra X. Variability of biochemical findings in patients with fra X may reflect the known high variability of the clinical syndrome.

UI MeSH Term Description Entries
D007858 Learning Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. Phenomenography
D008297 Male Males
D008570 Memory, Short-Term Remembrance of information for a few seconds to hours. Immediate Recall,Memory, Immediate,Working Memory,Memory, Shortterm,Immediate Memories,Immediate Memory,Immediate Recalls,Memories, Immediate,Memories, Short-Term,Memories, Shortterm,Memory, Short Term,Recall, Immediate,Recalls, Immediate,Short-Term Memories,Short-Term Memory,Shortterm Memories,Shortterm Memory,Working Memories
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477

Related Publications

E Berry-Kravis, and P R Huttenlocher
Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations.
November 1995, Pediatric research,
E Berry-Kravis, and P R Huttenlocher
The cyclic AMP phenotype of fragile X and autism.
October 2008, Neuroscience and biobehavioral reviews,
E Berry-Kravis, and P R Huttenlocher
Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome.
January 1993, American journal of medical genetics,
E Berry-Kravis, and P R Huttenlocher
The cyclic AMP cascade is altered in the fragile X nervous system.
September 2007, PloS one,
E Berry-Kravis, and P R Huttenlocher
Thymidylate metabolism in fragile X syndrome cells.
July 1985, Somatic cell and molecular genetics,
E Berry-Kravis, and P R Huttenlocher
Cyclic AMP in metabolism.
January 1971, Nature: New biology,
E Berry-Kravis, and P R Huttenlocher
[Metabolism of monocarbons and the fragile X syndrome].
December 1981, Bulletin de l'Academie nationale de medecine,
E Berry-Kravis, and P R Huttenlocher
[Fragile X chromosomes and fragile X syndrome].
October 2006, Ugeskrift for laeger,
E Berry-Kravis, and P R Huttenlocher
Fragile X syndrome vs fragile X-associated tremor/ataxia syndrome.
February 2007, Archives of neurology,
E Berry-Kravis, and P R Huttenlocher
Fragile X syndrome and fragile X-associated tremor ataxia syndrome.
January 2018, Handbook of clinical neurology,
Copied contents to your clipboard!